Skip to main content
. 2020 Dec 8;13:1756284820977402. doi: 10.1177/1756284820977402

Table 4.

Prevalence of sub-types of FGID in fibromyalgia and healthy controls from five studies (%).

Author IBS (C1)
Alternating constipation and diarrhoea (C*)
Bloating (or ‘gas’) (C2)
Constipation (C3)
Diarrhoea (C4)
Abdominal pain (D1)
Unspecified functional abdominal pain (D2)
Faecal incontinence (F1)
FMS NC FMS NC FMS NC FMS NC FMS NC FMS NC FMS NC FMS NC
Triadafilopoulos24 60.0 0 62.6 0 59.0 13.0 12.0 13.0 9.0 2.0a 54.0 4.0 - - - -
Sivri45 41.8 16.0 41.8 20.0 45.5 - 30.7 8.0 7.0 1.0 38.2 8.0 - - - -
Kurland49 81.0 - 61.0 - - - 15.2 - 4.8 - - - - - - -
Almansa51 39.0 3.0 - - 34 12.0 15.0 5.0 2.0 0 75.0 0.0 19.0 1.0 56.0 25.0
Marum41 95.0 - 22.2 - - - 69.4 - 8.3 - - - - - - -
FGID average b 67.2 52.9 65.4 21.3 6.0 57.1 19.0 56.0
a

Estimated from Triadafilopoulos Figure 2 (data not provided).

b

Calculated from studies reporting that FGID.

FGID, functional gastrointestinal disorder; FMS, fibromyalgia patients; NC, normal controls.